150 related articles for article (PubMed ID: 8652819)
1. Differential mechanisms targeting type 1 plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line.
Hill SA; Shaughnessy SG; Joshua P; Ribau J; Austin RC; Podor TJ
Blood; 1996 Jun; 87(12):5061-73. PubMed ID: 8652819
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Semliki Forest virus enhanced plasminogen activator inhibitor 1 expression and storage in the megakaryocytic cell line MEG-01.
Chuang JL; Schleef RR
J Cell Biochem; 2001; 82(2):277-89. PubMed ID: 11527153
[TBL] [Abstract][Full Text] [Related]
3. Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation.
Madoiwa S; Komatsu N; Mimuro J; Kimura K; Matsuda M; Sakata Y
Blood; 1999 Jul; 94(2):475-82. PubMed ID: 10397715
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated expression and packaging of tissue-type plasminogen activator in megakaryocytic cells.
Chuang JL; Schleef RR
Thromb Haemost; 2001 Jun; 85(6):1079-85. PubMed ID: 11434688
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cyclin D1 in the Dami megakaryocytic cell line causes growth arrest.
Wilhide CC; Van Dang C; Dipersio J; Kenedy AA; Bray PF
Blood; 1995 Jul; 86(1):294-304. PubMed ID: 7795236
[TBL] [Abstract][Full Text] [Related]
6. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.
Podor TJ; Singh D; Chindemi P; Foulon DM; McKelvie R; Weitz JI; Austin R; Boudreau G; Davies R
J Biol Chem; 2002 Mar; 277(9):7529-39. PubMed ID: 11744725
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin-induced Dami cells as a model for alpha-granule biogenesis.
Briquet-Laugier V; El Golli N; Nurden P; Lavenu-Bombled C; Dubart-Kupperschmitt A; Nurden A; Rosa JP
Platelets; 2004 Sep; 15(6):341-4. PubMed ID: 15370095
[TBL] [Abstract][Full Text] [Related]
8. Intra- and extracellular plasminogen activator inhibitor-1 regulate effect of vitronectin against radiation-induced endothelial cell death.
Hazawa M; Yasuda T; Saotome-Nakamura A; Tomiyama K; Obara C; Goto T; Tajima K
Vascul Pharmacol; 2016 Dec; 87():150-158. PubMed ID: 27650166
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 mRNA is expressed in platelets and megakaryocytes and the megakaryoblastic cell line CHRF-288.
Konkle BA; Schick PK; He X; Liu RJ; Mazur EM
Arterioscler Thromb; 1993 May; 13(5):669-74. PubMed ID: 8485117
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2.
Stefansson S; Lawrence DA; Argraves WS
J Biol Chem; 1996 Apr; 271(14):8215-20. PubMed ID: 8626514
[TBL] [Abstract][Full Text] [Related]
11. Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. Evidence that the binding protein is vitronectin.
Owensby DA; Morton PA; Wun TC; Schwartz AL
J Biol Chem; 1991 Mar; 266(7):4334-40. PubMed ID: 1705551
[TBL] [Abstract][Full Text] [Related]
12. On the role of c-Jun in the induction of PAI-1 gene expression by phorbol ester, serum, and IL-1alpha in HepG2 cells.
Arts J; Grimbergen J; Toet K; Kooistra T
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):39-46. PubMed ID: 9888864
[TBL] [Abstract][Full Text] [Related]
13. Interaction between protein kinase C and actin in megakaryocyte polyploidization.
Baatout S; Chatelain B; Staquet P; Symann M; Chatelain C
Anticancer Res; 1999; 19(5B):4193-8. PubMed ID: 10628374
[TBL] [Abstract][Full Text] [Related]
14. Expression of prostacyclin receptor in human megakaryocytes.
Sasaki Y; Takahashi T; Tanaka I; Nakamura K; Okuno Y; Nakagawa O; Narumiya S; Nakao K
Blood; 1997 Aug; 90(3):1039-46. PubMed ID: 9242534
[TBL] [Abstract][Full Text] [Related]
15. Role of c-Jun and proximal phorbol 12-myristate-13-acetate-(PMA)-responsive elements in the regulation of basal and PMA-stimulated plasminogen-activator inhibitor-1 gene expression in HepG2.
Arts J; Grimbergen J; Bosma PJ; Rahmsdorf HJ; Kooistra T
Eur J Biochem; 1996 Oct; 241(2):393-402. PubMed ID: 8917435
[TBL] [Abstract][Full Text] [Related]
16. Construction of a plasminogen activator inhibitor-1 variant without measurable affinity to vitronectin but otherwise normal.
Jensen JK; Durand MK; Skeldal S; Dupont DM; Bødker JS; Wind T; Andreasen PA
FEBS Lett; 2004 Jan; 556(1-3):175-9. PubMed ID: 14706846
[TBL] [Abstract][Full Text] [Related]
17. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn.
Schroeck F; Arroyo de Prada N; Sperl S; Schmitt M; Viktor M
Biol Chem; 2002; 383(7-8):1143-9. PubMed ID: 12437099
[TBL] [Abstract][Full Text] [Related]
18. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin.
Arroyo De Prada N; Schroeck F; Sinner EK; Muehlenweg B; Twellmeyer J; Sperl S; Wilhelm OG; Schmitt M; Magdolen V
Eur J Biochem; 2002 Jan; 269(1):184-92. PubMed ID: 11784312
[TBL] [Abstract][Full Text] [Related]
19. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.
Preissner KT; Grulich-Henn J; Ehrlich HJ; Declerck P; Justus C; Collen D; Pannekoek H; Müller-Berghaus G
J Biol Chem; 1990 Oct; 265(30):18490-8. PubMed ID: 1698787
[TBL] [Abstract][Full Text] [Related]
20. Type 1 plasminogen activator inhibitor induces multimerization of plasma vitronectin. A suggested mechanism for the generation of the tissue form of vitronectin in vivo.
Seiffert D; Loskutoff DJ
J Biol Chem; 1996 Nov; 271(47):29644-51. PubMed ID: 8939896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
